Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
130 participants
INTERVENTIONAL
2020-07-21
2020-09-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Isosorbide Mononitrate in Reducing Time in Induction of Labor in Post Date Women
NCT03854383
Intravaginal Isosorbide Mononitrate in Addition to Misoprostol Versus Misoprostol Only for Induction of Labor
NCT03523754
Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion
NCT03407521
Oral Misoprostol Solution in Comparison to Vaginal Misoprostol in Induction of Labor
NCT03863392
Vaginal Misoprostol With Intracervical Foley Catheter in Induction of Labor
NCT03682718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women receiving isosorbide mononitrates lower dose
women who will receive isosorbide mononitrates lower dose
Isosorbide Mononitrate 40 MG
giving women isosorbide mononitrate 40 MG
women receiving isosorbide mononitrates higher dose
women who will receive isosorbide mononitrates higher dose
Isosorbide Mononitrate 60 MG
giving women isosorbide mononitrate 60MG
Women receiving misoprostol
Women who will receive misoprostol
Misoprostol
Giving women misoprostol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Isosorbide Mononitrate 40 MG
giving women isosorbide mononitrate 40 MG
Isosorbide Mononitrate 60 MG
giving women isosorbide mononitrate 60MG
Misoprostol
Giving women misoprostol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Previous uterine scar.
3. Fetal malpresentation.
4. Multiple pregnancies.
18 Years
42 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Suez Canal University
OTHER
Aljazeera Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud Alalfy, PhD
Role: PRINCIPAL_INVESTIGATOR
Algezeera hospitaland National Research Centre ,Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Algazeerah
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ahmed Elgazzar, M.D
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
labour induction
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.